Theravance Biopharma Inc

Most Recent

  • uploads///EBAY
    Consumer

    Why the Baupost Group adds new position in eBay

    The Baupost Group added a stake in eBay Inc. (EBAY) that accounted for 3.62% of the fund’s total second quarter portfolio. eBay is a global technology company that enables commerce through three reportable segments—Marketplaces, Payments, and Enterprise.

    By Samantha Nielson
  • uploads///Noxafil and Cubicin
    Company & Industry Overviews

    Understanding the Performance of Merck’s Hospital Acute Care Drugs Noxafil and Cubicin

    In 4Q17, Merck’s (MRK) Cubicin reported revenues of $92 million, which was ~23% lower on a YoY (year-over-year) basis.

    By Daniel Collins
  • uploads///BaupostF
    Fund Managers

    Analyzing The Baupost Group’s Holdings in 4Q14

    The Baupost Group generated $21.5 billion in returns over its history. The recent 13F filing revealed that its 4Q14 portfolio declined more to $5.09 billion.

    By Samantha Nielson
  • uploads///TBPH
    Consumer

    Why the Baupost Group starts new position in Theravance Biopharma

    The Baupost Group added a position in Theravance Biopharma Inc. (TBPH) that accounted for 9.89% of the fund’s total second quarter portfolio. Theravance Biopharma was recently spun out of Theravance (THRX).

    By Samantha Nielson
  • Consumer

    Must-know: The Baupost Group’s 2Q14 positions

    The size of the fund’s U.S. long portfolio increased 48% to $6.14 billion in the second quarter from $4.14 billion in the first quarter. The fund’s top positions include Micron Technology, Idenix Pharmaceuticals, and Viasat.

    By Samantha Nielson
  • uploads///Graph
    Company & Industry Overviews

    Mylan: Why North America Is a Major Market

    In the third quarter, Mylan (MYL) reported net sales of $1.01 billion from the North American market—a 14% decline on a YoY basis.

    By Margaret Patrick
  • uploads///SEMI
    Consumer

    The Baupost Group opens new position in SunEdison Semiconductor

    The Baupost Group added a position in SunEdison Semiconductor (SEMI) that accounted for 1.14% of the fund’s total second quarter portfolio. SunEdison Semiconductor develops, manufactures, and sells silicon wafers to the semiconductor industry.

    By Samantha Nielson
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.